"Last hope": Eager Germans are prepared to pay for weight-loss drug

3 years ago by BrikoX to c/news

Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica Lenth from Hamburg has started putting money aside for a drug that she sees as a possible door to a life without obesity.
load all comments
mark_dennis1199 5 points 3 years ago

I don’t understand why insurance and health plans are denying paying for Wegovy. They rather shell out far more money for treatment of complications and co-mprbidities related to obesity than pay for the drug now? It’s being penny-wise and pound-foolish.

path: 0 1711345, hotness: undefined, score: 5, children: 3
southsamurai -1 points 3 years ago

It's still an off label use, from what I was told. That's the excuse anyway, but it's a common excuse for insurance refusals

path: 0 1711345 1711781, hotness: undefined, score: -1, children: 2
mark_dennis1199 3 points 3 years ago

Wegovy is indicated for the treatment of obesity. It’s Ozempic that’s being used off-label for weight loss.

path: 0 1711345 1711781 1712318, hotness: undefined, score: 3, children: 1
news
news

@lemmy.world

login for more options
38081
38673
9285

Welcome to the News community!

Rules:

1. Be civil

Attack the argument, not the person. No racism/sexism/bigotry. Good faith argumentation only. This includes accusing another user of being a bot or paid actor. Trolling is uncivil and is grounds for removal and/or a community ban. Do not respond to rule-breaking content; report it and move on.


2. All posts should contain a source (url) that is as reliable and unbiased as possible and must only contain one link.

Obvious biased sources will be removed at the mods’ discretion. Supporting links can be added in comments or posted separately but not to the post body. Sources may be checked for reliability using Wikipedia, MBFC, AdFontes, GroundNews, etc.


3. No bots, spam or self-promotion.

Only approved bots, which follow the guidelines for bots set by the instance, are allowed.


4. Post titles should be the same as the article used as source. Clickbait titles may be removed.

Posts which titles don’t match the source may be removed. If the site changed their headline, we may ask you to update the post title. Clickbait titles use hyperbolic language and do not accurately describe the article content. When necessary, post titles may be edited, clearly marked with [brackets], but may never be used to editorialize or comment on the content.


5. Only recent news is allowed.

Posts must be news from the most recent 30 days.


6. All posts must be news articles.

No opinion pieces, Listicles, editorials, videos, blogs, press releases, or celebrity gossip will be allowed. All posts will be judged on a case-by-case basis. Mods may use discretion to pre-approve videos or press releases from highly credible sources that provide unique, newsworthy content not available or possible in another format.


7. No duplicate posts.

If an article has already been posted, it will be removed. Different articles reporting on the same subject are permitted. If the post that matches your post is very old, we refer you to rule 5.


8. Misinformation is prohibited.

Misinformation / propaganda is strictly prohibited. Any comment or post containing or linking to misinformation will be removed. If you feel that your post has been removed in error, credible sources must be provided.


9. No link shorteners or news aggregators.

All posts must link to original article sources. You may include archival links in the post description. News aggregators such as Yahoo, Google, Hacker News, etc. should be avoided in favor of the original source link. Newswire services such as AP, Reuters, or AFP, are frequently republished and may be shared from other credible sources.


10. Don't copy entire article in your post body

For copyright reasons, you are not allowed to copy an entire article into your post body. This is an instance wide rule, that is strictly enforced in this community.

go to feed...